HIS
VYGR icon

Harvest Investment Services’s Voyager Therapeutics VYGR Stock Holding History

Harvest Investment Services’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-42,312
Closed -$250K – 161
2022
Q2 		$250K Buy
+42,312
New +$286K 0.19% 125

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Harvest Investment Services's VYGR Position: Q3 2022 in Review

Harvest Investment Services sold out of Voyager Therapeutics (VYGR) in Q3 2022, closing a stake of 42,312 shares — an estimated $250K sold.

Harvest Investment Services first reported a position in VYGR in Q2 2022 and held it in 1 quarter. The position peaked at $250K in Q2 2022. 69 funds tracked by Wall St. Rank hold VYGR as of Q3 2022.

  • Harvest Investment Services reported no remaining Voyager Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Harvest Investment Services sold 42,312 Voyager Therapeutics shares in Q3 2022, an estimated $250K.
  • Harvest Investment Services first reported a position in Voyager Therapeutics in Q2 2022 and held it in 1 quarter.
  • Harvest Investment Services's Voyager Therapeutics position peaked at $250K in Q2 2022.
  • 69 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2022.

Based on Harvest Investment Services's 13F filing for Q3 2022, filed 9 Nov 2022.